Atlas Trials

A Retrospective, Real-world Study of ELP Used in the Expectorant Treatment of Community-acquired Pneumonia

Clinical trial NCT05002192 · UNKNOWN

Trial details

NCT number
NCT05002192
Sponsor
Beijing Grand Johamu Pharmaceutical Company, Ltd.
Status
UNKNOWN
Study type
OBSERVATIONAL
Community-acquired Pneumonia
Start date
2020-09-01
Primary completion
2021-12-31
Enrollment
10000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.